{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:50:51Z","timestamp":1788587451501,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"French National Cancer Institute","doi-asserted-by":"publisher","award":["2019-1-PL SHS-01-IGR-1"],"award-info":[{"award-number":["2019-1-PL SHS-01-IGR-1"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.clgc.2025.102344","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T06:31:12Z","timestamp":1745562672000},"page":"102344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incidence of Bladder Cancer, Healthcare Pathways, and Economic Burden: A Real-World Observational Study From the French National Healthcare System Database"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2235-0012","authenticated-orcid":false,"given":"Ald\u00e9ric Masoandro","family":"Fraslin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1162-9165","authenticated-orcid":false,"given":"Simone","family":"Benhamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lebret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Radvanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Allory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3301-8795","authenticated-orcid":false,"given":"Maryam","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Bonastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102344_bib0001","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2025.102344_bib0002","unstructured":"SPF. Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989-2018 - Vessie n.d. https:\/\/www.santepubliquefrance.fr\/import\/survie-des-personnes-atteintes-de-cancer-en-france-metropolitaine-1989-2018-vessie (Accessed May 28, 2024)."},{"key":"10.1016\/j.clgc.2025.102344_bib0003","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/cncr.28397","article-title":"Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006","volume":"120","author":"Nielsen","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.clgc.2025.102344_bib0004","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/bju.12468","article-title":"Section of oncology, BAUS. Stage, grade and pathological characteristics of bladder cancer in the UK: british Association of Urological Surgeons (BAUS) urological tumour registry","volume":"113","author":"Boustead","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2025.102344_bib0005","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1186\/s12885-016-2832-x","article-title":"Incidence and survival of urothelial carcinoma of the urinary bladder in Norway 1981-2014","volume":"16","author":"Andreassen","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clgc.2025.102344_bib0006","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.clgc.2025.102344_bib0007","article-title":"European Association of Urology Guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 Guidelines","author":"Alfred Witjes","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102344_bib0008","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102344_bib0009","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-075942","article-title":"Cohort profile: cOBLAnCE: a French prospective cohort to study prognostic and predictive factors in bladder cancer and to generate real-world data on treatment patterns, resource use and quality of life","volume":"13","author":"Lebret","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.clgc.2025.102344_bib0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00345-023-04335-w","article-title":"Population characteristics, management, and survival outcomes in muscle-invasive urothelial carcinoma undergoing radical resection: the MINOTAUR study","volume":"41","author":"Roupret","year":"2023","journal-title":"World J Urol"},{"issue":"Suppl 4","key":"10.1016\/j.clgc.2025.102344_bib0011","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.respe.2017.05.004","article-title":"Value of a national administrative database to guide public decisions: from the syst\u00e8me national d'information interr\u00e9gimes de l'Assurance Maladie (SNIIRAM) to the syst\u00e8me national des donn\u00e9es de sant\u00e9 (SNDS) in France","volume":"65","author":"Tuppin","year":"2017","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.clgc.2025.102344_bib0012","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2458-9-33","article-title":"Ecological association between a deprivation index and mortality in France over the period 1997 \u20132001: variations with spatial scale, degree of urbanicity, age, gender and cause of death","volume":"9","author":"Rey","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/j.clgc.2025.102344_bib0013","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00125-012-2538-9","article-title":"Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study","volume":"55","author":"Neumann","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.clgc.2025.102344_bib0014","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clgc.2025.102344_bib0015","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MLR.0000000000000471","article-title":"The best use of the Charlson comorbidity index with electronic health care database to predict mortality","volume":"54","author":"Bannay","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.clgc.2025.102344_bib0016","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cai2.42","article-title":"Clustering of prostate cancer healthcare pathways in the French National Healthcare database","volume":"2","author":"Baulain","year":"2023","journal-title":"Cancer Innov"},{"key":"10.1016\/j.clgc.2025.102344_bib0017","article-title":"Clinical care pathways of patients with biliary tract cancer: a French nationwide longitudinal cohort study","volume":"202","author":"Tzedakis","year":"2024","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.clgc.2025.102344_bib0018","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/rssa.12125","article-title":"What matters in differences between life trajectories: a comparative review of sequence dissimilarity measures","volume":"179","author":"Studer","year":"2016","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/j.clgc.2025.102344_bib0019","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/01621459.1963.10500845","article-title":"Hierarchical grouping to optimize an objective function","volume":"58","author":"Ward","year":"1963","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.clgc.2025.102344_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v040.i04","article-title":"Analyzing and visualizing State sequences in R with TraMineR","volume":"40","author":"Gabadinho","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/j.clgc.2025.102344_bib0021","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.eururo.2014.01.006","article-title":"The economics of bladder cancer: costs and considerations of caring for this disease","volume":"66","author":"Svatek","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102344_bib0022","first-page":"51","article-title":"The real-world lifetime economic burden of urothelial carcinoma by stage at diagnosis","volume":"6","author":"Aly","year":"2020","journal-title":"J Clin Pathw Found Value-Based Care"},{"key":"10.1016\/j.clgc.2025.102344_bib0023","article-title":"The financial burden of localized and metastatic bladder cancer","author":"Scilipoti","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102344_bib0024","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 H.A.S. OPDIVO (nivolumab) - Carcinome Uroth\u00e9lial. Saint-Denis La Plaine: 2022. Accessed August 30, 2022. https:\/\/www.has-sante.fr\/jcms\/p_3382948\/fr\/opdivo-nivolumab-carcinome-urothelial-infiltrant-le-muscle-cuim#analyseEco."},{"key":"10.1016\/j.clgc.2025.102344_bib0025","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0007-4551(20)30278-2","article-title":"Immunoth\u00e9rapie des tumeurs de la vessie n'infiltrant pas le muscle : immunoth\u00e9rapies et TVNIM","volume":"107","author":"Loriot","year":"2020","journal-title":"Bull Cancer (Paris)"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500045X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S155876732500045X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T07:24:52Z","timestamp":1754551492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S155876732500045X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S155876732500045X"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102344","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence of Bladder Cancer, Healthcare Pathways, and Economic Burden: A Real-World Observational Study From the French National Healthcare System Database","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102344","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102344"}}